Adipokine Genetic Variations in predictingNAFLD Progression to NASH in Egyptian Patients
NCT ID: NCT04561895
Last Updated: 2020-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
224 participants
OBSERVATIONAL
2020-01-01
2020-09-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetic Pathways Leading to Fatty Liver and Atherogenic Dyslipidemia
NCT04209816
Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver Disease
NCT03986684
Characteristics of NAFLD Among Type 2 Diabetes Patients
NCT04999124
Prevalence of Non-alcoholic Fatty Liver Disease in Patients With Chronic Kidney Disease in Assiut
NCT06009250
Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD
NCT02285218
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
healthy volunteers with absence of NAFLD
DNA extraction
investigation of DNA polymorphism in patients suffering from NAFLD
test group
patients with confirmed NAFLD diagnosis
DNA extraction
investigation of DNA polymorphism in patients suffering from NAFLD
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DNA extraction
investigation of DNA polymorphism in patients suffering from NAFLD
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
\-
Exclusion Criteria
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Elsahel teaching hospital
UNKNOWN
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dalia K. Zaafar
lecturer of pharmacology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amal Ahmed, PhD
Role: PRINCIPAL_INVESTIGATOR
professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
El Sahel teaching hospital
Cairo, Shobra, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LC ElSahel
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.